BenchSci Blog

To date, BenchSci’s machine learning algorithm has decoded millions of Open Access scientific papers and over 3.7 million antibody products. However, OA papers only represent a subset of all scientific literature. Scientists generally use resources like Google or Pubmed, and are missing out on tools and other resources that publishers might offer. BenchSci therefore has initiated talks with publishers to make their content discoverable through BenchSci without a loss of readership or traffic to their sites.

It's that time of the month, BenchSci's monthly update!

At BenchSci, our goal is to help fellow scientists achieve biomedical discoveries faster.

One of our New Year resolutions here at BenchSci is to share our journey with the scientific community. We decided to start with a monthly blog post that will summarize what we have recently been up to.

More than two years have passed since our Chief Scientist, Dr. Thomas Leung, came up with the idea for BenchSci. Today, we are happy to announce that we have officially launched the beta version of BenchSci at 10 universities across North America.

We are proud to announce our first vendor partnership, Abgent, a global antibody manufacturer with more than 65,000 products.

We are thrilled to be covered in The Globe and Mail as one of the Canadian startups that make biomedical research faster, cheaper, and more accurate.

Any research scientist who works with antibodies has experienced the pain that we at BenchSci are trying to eliminate - failed experiments!